Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Class action filed
Acq. announced
Consulting agrmnt
Quarterly results
Director departure
Appointed director
CC transcript
|
|
ERESEARCHTECHNOLOGY INC (ERES)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/09/2012 |
8-K
| Entered into consulting agreement|
Docs:
|
"Agreement and Plan of Merger, by and among invivodata, Inc., Explorer Holdings, Inc., eResearchTechnology, Inc. (as successor to Explorer Acquisition Corp.), Impact Acquisition Corp. and Fortis Advisors LLC",
"Amended and Restated Certificate of Incorporation of eResearchTechnology, Inc",
"Amended and Restated Bylaws of eResearchTechnology, Inc",
"Genstar Capital Completes ERT Acquisition In A Take-Private Transaction PHILADELPHIA, July 3, 2012/PRNewswire/—ERT , a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations , announced today that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction valued at approximately $400 million. Dr. Jeffrey Litwin, who will continue to lead ERT as CEO, said, “As a private company we will continue to serve our customers and enhance our suite of products. We have been able to grow our company into a global leader, and, with Genstar's partnership, we will look for creative new ways to grow our business organically and identify new investment opportunities as part of our continued develo...",
"ERT Acquires invivodata to Establish the Industry's Most Experienced Provider of Clinical Outcome Assessment Solutions PHILADELPHIA, PA, July 9 2012 /PRNewswire/ - ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and Contract Research Organizations , announced today the acquisition of invivodata, Inc, a leading provider of electronic Patient Reported Outcomes solutions and PRO Consulting services, based in Pittsburgh, PA. The transaction was facilitated by the San Francisco-based private equity group, Genstar Capital, LLC who last week announced that they had completed the acquisition of ERT. The acquisition immediately positions ERT as a leader in Clinical Outcome Assessments . The combined organization will now offer sponsors, CROs and ot..." |
|
| 04/10/2012 |
8-K
| Form 8-K - Current report |
|
|